Therapeutic efficacy of CT-P59 against P.1 variant of SARS-CoV-2
S.-Y. Lee, D.-K. Ryu, b. Kang, H. Noh, J. Kim, J.-M. Seo, C. Kim, C. v. Baalen, A. S. Tijsma, H.-Y. Chung, M.-H. Lee, S.-S. Oh, J.-a. Choi, M. Song, K.-S. Kwon
This study evaluates CT-P59's efficacy against the P.1 SARS-CoV-2 variant through in vitro and in vivo tests, showing reduced in vitro neutralization but therapeutic benefit in mice.
bioRxiv · Jul 8, 2021 · PreprintMicrobiology